Clinical Trial

A Study of Outcomes Following Bio-Reinforced Canaloplasty in Eyes With Open-Angle Glaucoma

Study acronym: BOOST
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The goal of this study is to learn about outcomes after bio-reinforced canaloplasty surgery in patients with OAG. The key question the study aims to answer is: How much does the surgical procedure lower pressure inside the eye and what is the durability of this effect? Participants will return for periodic eye exams for 2 years following surgery.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2026-04-06; most recent amendment 2026-07-20.
Trial Details
NCT Number NCT07520175
Lead Sponsor Iantrek, Inc.
Conditions Open-Angle Glaucoma
Enrollment 300 participants
Start Date 2026-04-01
Primary Completion 2028-12 (estimated)
Study Completion 2029-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-22